Daxor Net Income
| DXR Stock | USD 12.54 0.33 2.70% |
As of the 4th of February, Daxor shows the Mean Deviation of 2.63, variance of 15.49, and Standard Deviation of 3.94. Daxor technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Daxor market risk adjusted performance and treynor ratio to decide if Daxor is priced favorably, providing market reflects its regular price of 12.54 per share. Given that Daxor has information ratio of (0.03), we urge you to verify Daxor's prevailing market performance to make sure the company can sustain itself at a future point.
Daxor Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 23.4717 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 482.7 K | 458.6 K | |
| Net Income Applicable To Common Shares | 4.7 M | 4.9 M | |
| Net Income From Continuing Ops | 616.8 K | 647.6 K | |
| Net Income Per Share | 0.13 | 0.15 | |
| Net Income Per E B T | 1.13 | 0.90 |
Daxor | Net Income | Build AI portfolio with Daxor Stock |
Evaluating Daxor's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Daxor's fundamental strength.
Latest Daxor's Net Income Growth Pattern
Below is the plot of the Net Income of Daxor over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Daxor financial statement analysis. It represents the amount of money remaining after all of Daxor operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Daxor's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Daxor's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 536.33 K | 10 Years Trend |
|
Net Income |
| Timeline |
Daxor Net Income Regression Statistics
| Arithmetic Mean | (796,218) | |
| Geometric Mean | 1,552,444 | |
| Coefficient Of Variation | (502.01) | |
| Mean Deviation | 2,798,188 | |
| Median | 280,640 | |
| Standard Deviation | 3,997,116 | |
| Sample Variance | 16T | |
| Range | 14.3M | |
| R-Value | 0.45 | |
| Mean Square Error | 13.7T | |
| R-Squared | 0.20 | |
| Significance | 0.07 | |
| Slope | 352,425 | |
| Total Sum of Squares | 255.6T |
Daxor Net Income History
Other Fundumenentals of Daxor
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Daxor Net Income component correlations
Daxor Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Daxor is extremely important. It helps to project a fair market value of Daxor Stock properly, considering its historical fundamentals such as Net Income. Since Daxor's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Daxor's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Daxor's interrelated accounts and indicators.
Click cells to compare fundamentals
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Daxor have expansion opportunities? Factors like these will boost the valuation of Daxor. Projected growth potential of Daxor fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Daxor demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth (0.36) | Earnings Share 0.16 | Revenue Per Share | Quarterly Revenue Growth (0.74) | Return On Assets |
The market value of Daxor is measured differently than its book value, which is the value of Daxor that is recorded on the company's balance sheet. Investors also form their own opinion of Daxor's value that differs from its market value or its book value, called intrinsic value, which is Daxor's true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because Daxor's market value can be influenced by many factors that don't directly affect Daxor's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Daxor's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Daxor should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Daxor's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Daxor 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Daxor's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Daxor.
| 11/06/2025 |
| 02/04/2026 |
If you would invest 0.00 in Daxor on November 6, 2025 and sell it all today you would earn a total of 0.00 from holding Daxor or generate 0.0% return on investment in Daxor over 90 days. Daxor is related to or competes with Nephros, CervoMed, Great Elm, Gain Therapeutics, NRX Pharmaceuticals, Adicet Bio, and Adagene. Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testin... More
Daxor Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Daxor's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Daxor upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 21.64 | |||
| Value At Risk | (5.48) | |||
| Potential Upside | 4.22 |
Daxor Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Daxor's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Daxor's standard deviation. In reality, there are many statistical measures that can use Daxor historical prices to predict the future Daxor's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.32) | |||
| Treynor Ratio | (0.07) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Daxor's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Daxor February 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.06) | |||
| Mean Deviation | 2.63 | |||
| Coefficient Of Variation | (5,027) | |||
| Standard Deviation | 3.94 | |||
| Variance | 15.49 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.32) | |||
| Treynor Ratio | (0.07) | |||
| Maximum Drawdown | 21.64 | |||
| Value At Risk | (5.48) | |||
| Potential Upside | 4.22 | |||
| Skewness | (0.72) | |||
| Kurtosis | 6.01 |
Daxor Backtested Returns
Daxor secures Sharpe Ratio (or Efficiency) of -0.0131, which denotes the company had a -0.0131 % return per unit of risk over the last 3 months. Daxor exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Daxor's Standard Deviation of 3.94, mean deviation of 2.63, and Variance of 15.49 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.32, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Daxor will likely underperform. At this point, Daxor has a negative expected return of -0.0388%. Please make sure to confirm Daxor's value at risk, rate of daily change, as well as the relationship between the Rate Of Daily Change and relative strength index , to decide if Daxor performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.47 |
Average predictability
Daxor has average predictability. Overlapping area represents the amount of predictability between Daxor time series from 6th of November 2025 to 21st of December 2025 and 21st of December 2025 to 4th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Daxor price movement. The serial correlation of 0.47 indicates that about 47.0% of current Daxor price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.47 | |
| Spearman Rank Test | 0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 0.52 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Daxor Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Daxor reported net income of 536.33 K. This is 99.84% lower than that of the Health Care Equipment & Supplies sector and 99.46% lower than that of the Health Care industry. The net income for all United States stocks is 99.91% higher than that of the company.
Daxor Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Daxor's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Daxor could also be used in its relative valuation, which is a method of valuing Daxor by comparing valuation metrics of similar companies.Daxor is currently under evaluation in net income category among its peers.
Daxor ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Daxor's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Daxor's managers, analysts, and investors.Environmental | Governance | Social |
Daxor Institutional Holders
Institutional Holdings refers to the ownership stake in Daxor that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Daxor's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Daxor's value.| Shares | Vanguard Group Inc | 2025-06-30 | 49 K | Renaissance Technologies Corp | 2025-06-30 | 28 K | Keyes Stange & Wooten Wealth Management Llc | 2025-06-30 | 15.9 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 3.6 K | Sbi Securities Co Ltd | 2025-06-30 | 3.1 K | Jpmorgan Chase & Co | 2025-06-30 | 4.0 | Wells Fargo & Co | 2025-06-30 | 0.0 | Advisor Group Holdings, Inc. | 2025-03-31 | 0.0 | Princeton Global Asset Management Llc | 2025-03-31 | 0.0 | Ubs Group Ag | 2025-06-30 | 0.0 |
Daxor Fundamentals
| Return On Equity | 0.0526 | ||||
| Return On Asset | -0.0251 | ||||
| Profit Margin | 27.11 % | ||||
| Operating Margin | (15.09) % | ||||
| Current Valuation | 42.93 M | ||||
| Shares Outstanding | 5.83 M | ||||
| Shares Owned By Insiders | 48.89 % | ||||
| Shares Owned By Institutions | 1.46 % | ||||
| Number Of Shares Shorted | 7.31 K | ||||
| Price To Earning | 10.77 X | ||||
| Price To Book | 2.17 X | ||||
| Price To Sales | 1,102 X | ||||
| Revenue | 2.13 M | ||||
| Gross Profit | 66.31 K | ||||
| EBITDA | 2.06 M | ||||
| Net Income | 536.33 K | ||||
| Cash And Equivalents | 59.62 K | ||||
| Cash Per Share | 13.31 X | ||||
| Total Debt | 729.97 K | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 2.98 X | ||||
| Book Value Per Share | 7.15 X | ||||
| Cash Flow From Operations | 25.69 K | ||||
| Short Ratio | 1.54 X | ||||
| Earnings Per Share | 0.16 X | ||||
| Target Price | 22.0 | ||||
| Beta | 0.028 | ||||
| Market Capitalization | 73.04 M | ||||
| Total Asset | 36.63 M | ||||
| Retained Earnings | 25.63 M | ||||
| Working Capital | 32.42 M | ||||
| Current Asset | 81.69 M | ||||
| Current Liabilities | 49.26 M | ||||
| Five Year Return | 0.52 % | ||||
| Net Asset | 36.63 M |
About Daxor Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Daxor's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Daxor using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Daxor based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Daxor
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Daxor position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daxor will appreciate offsetting losses from the drop in the long position's value.Moving against Daxor Stock
The ability to find closely correlated positions to Daxor could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Daxor when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Daxor - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Daxor to buy it.
The correlation of Daxor is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Daxor moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Daxor moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Daxor can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Daxor Stock Analysis
When running Daxor's price analysis, check to measure Daxor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daxor is operating at the current time. Most of Daxor's value examination focuses on studying past and present price action to predict the probability of Daxor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daxor's price. Additionally, you may evaluate how the addition of Daxor to your portfolios can decrease your overall portfolio volatility.